|
|
Blood, 15 May 2006, Vol. 107, No. 10, pp. 3902-3906.
Prepublished online as a Blood First Edition Paper on February 2, 2006; DOI 10.1182/blood-2005-09-3687.
Previous Article | Next Article 
Submitted September 13, 2005
Accepted January 12, 2006
Glycoprotein VI-dependent and -independent pathways of thrombus formation in vivo
Christophe Dubois, Laurence Panicot-Dubois, Glenn Merrill-Skoloff, Bruce Furie, and Barbara C Furie*
Division of Hemostasis and Thrombosis Research, Center for Vascular Biology Research, Beth Israel Deaconess Medical Center, Boston, MA, USA; Department of Medicine, Harvard Medical School, Boston, MA, USA
* Corresponding author; email: bfurie1{at}bidmc.harvard.edu.
The role of the collagen receptor glycoprotein VI (GPVI) in arteriolar thrombus formation was studied in FcR null mice (FcR -/-) lacking platelet surface GPVI. Thrombi were induced with severe or mild FeCl3 injury. Collagen exposure was significantly delayed and diminished in mild compared to severe FeCl3 injury. Times to initial thrombus formation and vessel occlusion were delayed in FcR -/- compared to wild-type mice after severe injury. Platelet accumulation in wild-type mice was decreased after mild compared to severe injury. However, there was little difference between platelet accumulation after severe or mild injury in FcR -/-. These data indicate a significant role for GPVI in FeCl3-induced thrombus formation. Pretreatment of wild-type mice with lepirudin further impaired mild FeCl3-induced thrombus formation demonstrating a role for thrombin. Laser-induced thrombus formation in wild-type and FcR -/- was comparable. Collagen exposure to circulating blood was undetectable after laser injury. Normalized for thrombus size, thrombus-associated tissue factor was 5-fold higher in laser-induced thrombi than in severe FeCl3-induced thrombi. Thus, platelet activation by thrombin appears to be more important after laser injury than platelet activation by GPVI-collagen. It may thus be important when considering targets for antithrombotic therapy to employ multiple animal models with diverse pathways to thrombus formation.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. M. Thomas, L. Panicot-Dubois, R. Lacroix, F. Dignat-George, D. Lombardo, and C. Dubois
Cancer cell-derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo
J. Exp. Med.,
August 31, 2009;
206(9):
1913 - 1927.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. J. Graham, Q. Ren, J. R. Dilks, P. Blair, S. W. Whiteheart, and R. Flaumenhaft
Endobrevin/VAMP-8-dependent dense granule release mediates thrombus formation in vivo
Blood,
July 30, 2009;
114(5):
1083 - 1090.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. A. Senis, M. G. Tomlinson, S. Ellison, A. Mazharian, J. Lim, Y. Zhao, K. N. Kornerup, J. M. Auger, S. G. Thomas, T. Dhanjal, et al.
The tyrosine phosphatase CD148 is an essential positive regulator of platelet activation and thrombosis
Blood,
May 14, 2009;
113(20):
4942 - 4954.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Furie and B. C. Furie
Mechanisms of Thrombus Formation
N. Engl. J. Med.,
August 28, 2008;
359(9):
938 - 949.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Neyman, J. Gewirtz, and M. Poncz
Analysis of the spatial and temporal characteristics of platelet-delivered factor VIII-based clots
Blood,
August 15, 2008;
112(4):
1101 - 1108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. A. Bezman, L. Lian, C. S. Abrams, L. F. Brass, M. L. Kahn, M. S. Jordan, and G. A. Koretzky
Requirements of SLP76 tyrosines in ITAM and integrin receptor signaling and in platelet function in vivo
J. Exp. Med.,
August 4, 2008;
205(8):
1775 - 1788.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Marx, O. D. Christophe, P. J. Lenting, A. Rupin, M.-O. Vallez, T. J. Verbeuren, and C. V. Denis
Altered thrombus formation in von Willebrand factor-deficient mice expressing von Willebrand factor variants with defective binding to collagen or GPIIbIIIa
Blood,
August 1, 2008;
112(3):
603 - 609.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. N. Bernatchez, L. Acevedo, C. Fernandez-Hernando, T. Murata, C. Chalouni, J. Kim, H. Erdjument-Bromage, V. Shah, J.-P. Gratton, E. M. McNally, et al.
Myoferlin Regulates Vascular Endothelial Growth Factor Receptor-2 Stability and Function
J. Biol. Chem.,
October 19, 2007;
282(42):
30745 - 30753.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Westrick, M. E. Winn, and D. T. Eitzman
Murine Models of Vascular Thrombosis
Arterioscler Thromb Vasc Biol,
October 1, 2007;
27(10):
2079 - 2093.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Ragab, S. Severin, M.-P. Gratacap, E. Aguado, M. Malissen, M. Jandrot-Perrus, B. Malissen, J. Ragab-Thomas, and B. Payrastre
Roles of the C-terminal tyrosine residues of LAT in GPVI-induced platelet activation: insights into the mechanism of PLC{gamma}2 activation
Blood,
October 1, 2007;
110(7):
2466 - 2474.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Rabie, D. Varga-Szabo, M. Bender, R. Pozgaj, F. Lanza, T. Saito, S. P. Watson, and B. Nieswandt
Diverging signaling events control the pathway of GPVI down-regulation in vivo
Blood,
July 15, 2007;
110(2):
529 - 535.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Li, S. Lockyer, A. Concepcion, X. Gong, H. Takizawa, M. Guertin, Y. Matsumoto, J. Kambayashi, N. N. Tandon, and Y. Liu
The Fab Fragment of a Novel Anti-GPVI Monoclonal Antibody, OM4, Reduces In Vivo Thrombosis Without Bleeding Risk in Rats
Arterioscler Thromb Vasc Biol,
May 1, 2007;
27(5):
1199 - 1205.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. J.H. Sachs and B. Nieswandt
In Vivo Thrombus Formation in Murine Models
Circ. Res.,
April 13, 2007;
100(7):
979 - 991.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. V. Denis and D. D. Wagner
Platelet Adhesion Receptors and Their Ligands in Mouse Models of Thrombosis
Arterioscler Thromb Vasc Biol,
April 1, 2007;
27(4):
728 - 739.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Zhu, W. Bergmeier, J. Wu, H. Jiang, T. J. Stalker, M. Cieslak, R. Fan, L. Boumsell, A. Kumanogoh, H. Kikutani, et al.
Regulated surface expression and shedding support a dual role for semaphorin 4D in platelet responses to vascular injury
PNAS,
January 30, 2007;
104(5):
1621 - 1626.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. R. Vandendries, J. R. Hamilton, S. R. Coughlin, B. Furie, and B. C. Furie
Par4 is required for platelet thrombus propagation but not fibrin generation in a mouse model of thrombosis
PNAS,
January 2, 2007;
104(1):
288 - 292.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Strassel, C. Nonne, A. Eckly, T. David, C. Leon, M. Freund, J.-P. Cazenave, C. Gachet, and F. Lanza
Decreased Thrombotic Tendency in Mouse Models of the Bernard-Soulier Syndrome
Arterioscler Thromb Vasc Biol,
January 1, 2007;
27(1):
241 - 247.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. F. Samaha and M. L. Kahn
Novel Platelet and Vascular Roles for Immunoreceptor Signaling
Arterioscler Thromb Vasc Biol,
December 1, 2006;
26(12):
2588 - 2593.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Dubois, L. Panicot-Dubois, J. F. Gainor, B. C. Furie, and B. Furie
Thrombin-Dependent Platelet Activation Is VWF-Independent during Thrombus Formation In Vivo.
Blood (ASH Annual Meeting Abstracts),
November 16, 2006;
108(11):
1510 - 1510.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Liu, M. E. Fitzgerald, M. C. Berndt, C. W. Jackson, and T. K. Gartner
Bruton tyrosine kinase is essential for botrocetin/VWF-induced signaling and GPIb-dependent thrombus formation in vivo
Blood,
October 15, 2006;
108(8):
2596 - 2603.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Mangin, C. L. Yap, C. Nonne, S. A. Sturgeon, I. Goncalves, Y. Yuan, S. M. Schoenwaelder, C. E. Wright, F. Lanza, and S. P. Jackson
Thrombin overcomes the thrombosis defect associated with platelet GPVI/FcR{gamma} deficiency
Blood,
June 1, 2006;
107(11):
4346 - 4353.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|